Abstract
In vitro susceptibility profiles of 58 Paecilomyces clinical isolates are reported. Amphotericin B, itraconazole, and echinocandins showed poor activity against Paecilomyces lilacinus, while the new triazoles were active against it. Paecilomyces variotii exhibited a different susceptibility pattern, being susceptible to most antifungal agents apart from voriconazole and ravuconazole.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amphotericin B / pharmacology
-
Antifungal Agents / pharmacology*
-
DNA, Fungal / genetics
-
DNA, Ribosomal / genetics
-
Echinocandins / pharmacology
-
Itraconazole / pharmacology
-
Microbial Sensitivity Tests
-
Paecilomyces / classification
-
Paecilomyces / drug effects*
-
Paecilomyces / genetics*
-
Phylogeny
Substances
-
Antifungal Agents
-
DNA, Fungal
-
DNA, Ribosomal
-
Echinocandins
-
Itraconazole
-
Amphotericin B